Overall, our study suggested that tFNAs-siRUNX1 can mitigate Bcl-2/Bax-mediated apoptosis, leading to a partial reduction in initial perfusion loss or vascular breakdown that ultimately results in retinal ischemia. The gene discussed is BCL2; the disease is retinal ischemia.